Prosecution Insights
Last updated: November 08, 2026
Application No. 18/722,735

A TANK FOR A BIO-PHARMA PROCESS

Non-Final OA §102§103§112
Filed
Jun 21, 2024
Priority
Dec 21, 2021 — EU 21216595.5 +1 more
Examiner
ABEL, LENORA A
Art Unit
1799
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Estr Biosystems GmbH
OA Round
1 (Non-Final)
69%
Grant Probability
Favorable
1-2
OA Rounds
10m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 69% — above average
69%
Career Allowance Rate
146 granted / 212 resolved
+3.9% vs TC avg
Strong +33% interview lift
Without
With
+33.4%
Interview Lift
resolved cases with interview
Typical timeline
3y 2m
Avg Prosecution
32 currently pending
Career history
253
Total Applications
across all art units

Statute-Specific Performance

§101
0.4%
-39.6% vs TC avg
§103
53.8%
+13.8% vs TC avg
§102
28.1%
-11.9% vs TC avg
§112
15.9%
-24.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 212 resolved cases

Office Action

§102 §103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Priority Receipt is acknowledged of certified copies of papers required by 37 CFR 1.55. Information Disclosure Statement The information disclosure statements (IDS) submitted on 06/21/2024, 10/01/2025, and 01/16/2026 is in compliance with the provisions of 37 CFR 1.97. Accordingly, the information disclosure statements are being considered by the examiner. Claim Interpretation The following is a quotation of 35 U.S.C. 112(f): (f) Element in Claim for a Combination. – An element in a claim for a combination may be expressed as a means or step for performing a specified function without the recital of structure, material, or acts in support thereof, and such claim shall be construed to cover the corresponding structure, material, or acts described in the specification and equivalents thereof. The following is a quotation of pre-AIA 35 U.S.C. 112, sixth paragraph: An element in a claim for a combination may be expressed as a means or step for performing a specified function without the recital of structure, material, or acts in support thereof, and such claim shall be construed to cover the corresponding structure, material, or acts described in the specification and equivalents thereof. The claims in this application are given their broadest reasonable interpretation using the plain meaning of the claim language in light of the specification as it would be understood by one of ordinary skill in the art. The broadest reasonable interpretation of a claim element (also commonly referred to as a claim limitation) is limited by the description in the specification when 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is invoked. As explained in MPEP § 2181, subsection I, claim limitations that meet the following three-prong test will be interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph: (A) the claim limitation uses the term “means” or “step” or a term used as a substitute for “means” that is a generic placeholder (also called a nonce term or a non-structural term having no specific structural meaning) for performing the claimed function; (B) the term “means” or “step” or the generic placeholder is modified by functional language, typically, but not always linked by the transition word “for” (e.g., “means for”) or another linking word or phrase, such as “configured to” or “so that”; and (C) the term “means” or “step” or the generic placeholder is not modified by sufficient structure, material, or acts for performing the claimed function. Use of the word “means” (or “step”) in a claim with functional language creates a rebuttable presumption that the claim limitation is to be treated in accordance with 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. The presumption that the claim limitation is interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is rebutted when the claim limitation recites sufficient structure, material, or acts to entirely perform the recited function. Absence of the word “means” (or “step”) in a claim creates a rebuttable presumption that the claim limitation is not to be treated in accordance with 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. The presumption that the claim limitation is not interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is rebutted when the claim limitation recites function without reciting sufficient structure, material or acts to entirely perform the recited function. Claim limitations in this application that use the word “means” (or “step”) are being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, except as otherwise indicated in an Office action. Conversely, claim limitations in this application that do not use the word “means” (or “step”) are not being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, except as otherwise indicated in an Office action. This application includes one or more claim limitations that do use the word “means” and “step,” and are nonetheless being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, because the claim limitation(s) uses a generic placeholder that is coupled with functional language without reciting sufficient structure to perform the recited function and the generic placeholder is not preceded by a structural modifier. Such claim limitation(s) is/are: “assembly-connecting means” in 8; “connector means” in claim 10; “actuating means” and “operating means” in claim 13; “steps” in claim 15. Because this/these claim limitation(s) is/are being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, it/they is/are being interpreted to cover the corresponding structure described in the specification as performing the claimed function, and equivalents thereof. If applicant does not intend to have this/these limitation(s) interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, applicant may: (1) amend the claim limitation(s) to avoid it/them being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph (e.g., by reciting sufficient structure to perform the claimed function); or (2) present a sufficient showing that the claim limitation(s) recite(s) sufficient structure to perform the claimed function so as to avoid it/them being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-15 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. The term “particularly” in claims 7 and 9 is a relative term which renders the claim indefinite. The term “particularly” is not defined by the claim, the specification does not provide a standard for ascertaining the requisite degree, and one of ordinary skill in the art would not be reasonably apprised of the scope of the invention. Moreover, the specification of the instant application does not provide a definition for said term. The term “types” in claim 7 is a relative term which renders the claim indefinite. The term “types” is not defined by the claim, the specification does not provide a standard for ascertaining the requisite degree, and one of ordinary skill in the art would not be reasonably apprised of the scope of the invention. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1-2, 4, 7-8, 10, and 15 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Bernate et al. (US 2020/0080045 A1-hereafter “Bernate”). Regarding claim 1, Bernate discloses a reservoir element for a tank of a bio-pharma process line (reservoir assembly 1250, para. [0078], Fig. 1Q to be used in a tangential flow assembly; further, Bernate discloses an invention relating to a cell growth, concentration and medium exchange device/module for growing and concentrating cells and automated cell processing, para. [0043]). “a body element and at least one shell element”: Fig. 1Q of Bernate shows a housing or body element of the assembly 1250 and the outer structural component of assembly 1250—the shell. “the body element having a first end and a second end, being opposite the first end,”: Fig. 1Q of Bernate shows an upper end and an opposing lower end of the housing of assembly 1250. “each of the first and second ends including an orifice, and wherein the body element tapers from the first end to the second end, wherein an inner volume is defined between the first and second ends,”: Fig. 1Q of Bernate shows an opening disposed on the top of the housing of assembly 1250 and an opening disposed at the bottom of housing 1250, the inner volume is defined between the opposing ends via retentate reservoirs 1252. Further, the body of reservoirs 1252 tapers from the upper end to the lower of assembly 1250. “and wherein the body element and/or the at least one shell element include at least one groove”: Bernate discloses grooves 1232 (para. [0078], Fig. 1Q). It should be noted that that the term “and/or” in the claim is being interpreted to indicate that one of the clauses needs to be met by the prior art in order to anticipate or render the instant claim obvious. “wherein the at least one shell element is fixedly attached to the body element so that the body element and the at least one shell element sandwich the groove in between forming at least one channel,”: Fig. 1Q of Bernate shows the housing of assembly 1250 includes a portion attached to the shell or outer portion or sides of assembly 1250 form a channel of reservoirs 1252 to accommodate pneumatic ports (now shown, para. [0078], Fig. 1Q). “the at least one channel being adapted for guiding at least one biochemical medium and/or an operating medium.”: Bernate discloses ports 1228 of reservoir assembly 1250 (para. [0078], Fig. 1Q). It should be noted that that the term “and/or” in the claim is being interpreted to indicate that one of the clauses needs to be met by the prior art in order to anticipate or render the instant claim obvious. Regarding claim 2, a portion of reservoir assembly 1250 has a polygonal shape of the cross-section (reservoir 1254, which has more than one side, Fig. 1Q of Bernate). Regarding claim 4, Fig. 1Q of Bernate shows plate element (shown below in annotated Fig. 1Q below, where the plate element is attached to a first end of the body of assembly 1250); the plate element shown in annotated Fig. 1Q, has a groove which can form a channel (also discussed above in claim 1); the port assembly 1250 form a channel of reservoirs 1252 to accommodate pneumatic ports (now shown, para. [0078], Fig. 1Q). PNG media_image1.png 584 460 media_image1.png Greyscale Regarding claim 7, Bernate discloses reservoir assembly 1250 includes a port with a respective channel, shown in Fig. 1Q. Further, Bernate discloses various ports (ports 1226 and 1228) of the reservoir assembly 1250 (para. [0078]); at least one filter (filters or membranes appropriate for use in the TFF device/module are those that are solvent resistant, are contamination free during filtration, and are able to retain the types and sizes of cells of interest, para. [0057]). Also, Bernate discloses the material used to fabricate the TFF device/module is thermally-conductive so that the cell culture may be heated or cooled to a desired temperature (para. 0063]). Further, Bernate discloses various valve types such solenoid 3-way valves, two pressure sensors, two proportional valves, a pump capable of delivering pressures of –5 to 30 psi and filters positioned in between the pneumatics and the reservoirs and where the 3-way solenoid valves (para. [0072]); Bernate discloses a pneumatic actuator with fluid transfer ports 1242 and pneumatic ports 1230 (para. [0093]). Regarding claim 8, Bernate discloses a means to couple the retentate member, the membrane, the permeate member, and the reservoir assembly (para. [0009]). It should be noted that that the term “and/or” in the claim is being interpreted to indicate that one of the clauses needs to be met by the prior art in order to anticipate or render the instant claim obvious. Regarding claim 10, Bernate discloses a top plate element shown Fig. 1Q of reservoir 1250 (the plate-like structure of assembly 1250 disposed on the upper portion and lower portion); reservoir assembly 1250 includes a sidewall, a top plate element and a bottom plate element (shown in Fig. 1Q and discussed above). Further, Bernate discloses reservoirs 1252 are used to contain the cells and medium as the cells are transferred through the flow channel and into the retentate reservoirs during cell concentration and/or growth (para. [0078]); flow channel disposed in permeate member (para. [0078]). It should be noted that that the term “and/or” in the claim is being interpreted to indicate that one of the clauses needs to be met by the prior art in order to anticipate or render the instant claim obvious. Regarding claim 15, Bernate discloses automated multi-module cell processing system (para. [0018]). Further, Bernate discloses a tank discussed above in claim 10; a top plate and a bottom plate and side wall (shown above in annotated Fig. 1Q), where the sidewall, top and bottom plate of assembly 1250 form a reservoir 1252 for receiving a medium). Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claims 3, 6, 9, and 11-12 are rejected under 35 U.S.C. 103 as being unpatentable over Bernate et al. (US 2020/0080045 A1-hereafter “Bernate”) as applied to claim 1 above, and further in view of Goral (US 2023/0009199 A1-hereafter “Goral”, has an earlier effective date as of the provisional application). Regarding claims 3, 6, 9, and 11, Bernate discloses the invention discussed above in claim 1. Also, Bernate discloses multiple reservoir elements, and Bernate discloses first ends and second ends of the reservoir assembly 1250 (annotated Fig. 1Q above shows the first and second ends of the reservoirs have the same size and shape), discussed above. Bernate does not explicitly teach stackable reservoir elements. Goral discloses a modular and stacked cell culture system that includes a standalone cell culture subunit with an interior cavity to house a cell culture substrate in a cell culture space (Abstract) and Goral discloses a stacked configuration of multiple units 50 interlocked by using threaded connections (the sealing face for claim 6, para. [0029], Fig. 4). It should be noted that that the term “and/or” in the claim is being interpreted to indicate that one of the clauses needs to be met by the prior art in order to anticipate or render the instant claim obvious. It would have been obvious to a person having ordinary skill in the art before the effective filing date of the invention to take the reservoir assembly of Bernate to include multiple reservoir elements stackable within each other as taught by Goral, because Goral teaches simultaneously running identical bioreactors while having a flexibility of maintaining different cell culture conditions will allow end users to quickly identify the optimal bioprocess conditions (para. [0037]). Regarding claim 12, a different embodiment of Bernate discloses a support rail adapted to support two at least two tanks (shown below in annotated Fig. 1S). It should be noted that that the term “and/or” in the claim is being interpreted to indicate that one of the clauses needs to be met by the prior art in order to anticipate or render the instant claim obvious. PNG media_image2.png 747 746 media_image2.png Greyscale Allowable Subject Matter Claims 13-14 would be allowable if rewritten to overcome the rejection(s) under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), 2nd paragraph, set forth in this Office action and to include all of the limitations of the base claim and any intervening claims. Moreover, It should be noted that that the term “and/or” in the claim is being interpreted to indicate that one of the clauses needs to be met by the prior art in order to anticipate or render the instant claim obvious. The following is a statement of reasons for the indication of allowable subject matter: for dependent claim 13, the prior art fails to suggest or singly or in combination teach the following claim limitations: a clean room bag that comprises at least one foil portion, wherein the clean room bag is configured to receive at least one tank and to provide a clean room environment for the at least one tank when the at least one tank is received in the clean room bag, wherein the at least one tank is accessible with a handling manipulator from the outside of the clean room bag, the system optionally further comprising at least one adaptor plate element, wherein the adaptor plate element is associated with at least one tank and can be installed on the at least one tank, so that one of the at least one foil portions of the clean room bag is sandwiched between an access plate element of the tank and the adaptor plate element, wherein at least one of the top plate element, the at least one sidewall element and the bottom plate element is said access plate element, wherein the adaptor plate element is configured to define at least one access point to provide access to the tank from the outside of the clean room bag, via the access plate element, wherein further optionally the adaptor plate element is configured to cover a filter and/or a port of the tank at least partially, and wherein the foil portion is provided removably and/or pierceably in an area of the filter and/or port of the tank to provide access to the tank and/or, wherein the adaptor plate element is configured to support an actuating means of a valve and/or an operating means of the tank, and wherein the foil portion is provided removably and/or pierceably in an area of the actuating means of a valve and/or an operating means of the tank to provide access to the tank, where these limitations are in combination with the claim as a whole. The closest prior art is Bernate et al. (US 2020/0080045 A1-hereafter “Bernate”) and Goral (US 2023/0009199 A1-hereafter “Goral”). Bernate discloses a disclosure providing a cell growth, buffer exchange, and/or cell concentration/filtration device that may be used as a stand- alone device or as a module configured to be used in an automated multi-module cell processing environment. Goral discloses a modular and stacked cell culture system that includes a standalone cell culture subunit with an interior cavity to house a cell culture substrate in a cell culture space, a fluid inlet to supply fluid to the cell culture space, and a fluid outlet to remove fluid from the cavity. The cavity is arranged for fluid to flow in from the fluid inlet, then through the cell culture space, and then out through the fluid outlet. However, Bernate and Goral do not teach or fairly suggest a clean room bag that comprises at least one foil portion, wherein the clean room bag is configured to receive at least one tank and to provide a clean room environment for the at least one tank when the at least one tank is received in the clean room bag, wherein the at least one tank is accessible with a handling manipulator from the outside of the clean room bag, the system optionally further comprising at least one adaptor plate element, wherein the adaptor plate element is associated with at least one tank and can be installed on the at least one tank, so that one of the at least one foil portions of the clean room bag is sandwiched between an access plate element of the tank and the adaptor plate element, wherein at least one of the top plate element, the at least one sidewall element and the bottom plate element is said access plate element, wherein the adaptor plate element is configured to define at least one access point to provide access to the tank from the outside of the clean room bag, via the access plate element, wherein further optionally the adaptor plate element is configured to cover a filter and/or a port of the tank at least partially, and wherein the foil portion is provided removably and/or pierceably in an area of the filter and/or port of the tank to provide access to the tank and/or, wherein the adaptor plate element is configured to support an actuating means of a valve and/or an operating means of the tank, and wherein the foil portion is provided removably and/or pierceably in an area of the actuating means of a valve and/or an operating means of the tank to provide access to the tank. The following is a statement of reasons for the indication of allowable subject matter: for dependent claim 14, the prior art fails to suggest or singly or in combination teach the following claim limitations: a clean room bag, for being used in system according to claim 10, the clean room bag being configured to receive at least one tank and to provide a clean room environment for the at least one tank when the at least one tank is received in the clean room bag, wherein the clean room bag comprises at least one foil portion, that is adapted to be sandwiched between an access plate element of the tank and an adaptor plate element, so as to define at least one access point to provide access to the tank from the outside of the clean room bag, via the access plate element, the clean room bag further comprising at least one support rail for guiding at least one received assembled tank within the clean room bag, the support rail being adapted to support at least two tanks, wherein the support rail may engage with the top plate elements and/or the sidewall elements of the respective tanks, so that the top plate elements of tanks with different height dimensions are arranged on the same level, when the tanks are supported by the support rail, wherein the support rail may be formed from multiple support rail sections, so that the clean room bag is foldable, where these limitations are in combination with the claim as a whole. The closest prior art is Bernate et al. (US 2020/0080045 A1-hereafter “Bernate”) and Goral (US 2023/0009199 A1-hereafter “Goral”). Bernate discloses a disclosure providing a cell growth, buffer exchange, and/or cell concentration/filtration device that may be used as a stand- alone device or as a module configured to be used in an automated multi-module cell processing environment. Goral discloses a modular and stacked cell culture system that includes a standalone cell culture subunit with an interior cavity to house a cell culture substrate in a cell culture space, a fluid inlet to supply fluid to the cell culture space, and a fluid outlet to remove fluid from the cavity. The cavity is arranged for fluid to flow in from the fluid inlet, then through the cell culture space, and then out through the fluid outlet. However, Bernate and Goral do not teach or fairly suggest a clean room bag, for being used in system according to claim 10, the clean room bag being configured to receive at least one tank and to provide a clean room environment for the at least one tank when the at least one tank is received in the clean room bag, wherein the clean room bag comprises at least one foil portion, that is adapted to be sandwiched between an access plate element of the tank and an adaptor plate element, so as to define at least one access point to provide access to the tank from the outside of the clean room bag, via the access plate element, the clean room bag further comprising at least one support rail for guiding at least one received assembled tank within the clean room bag, the support rail being adapted to support at least two tanks, wherein the support rail may engage with the top plate elements and/or the sidewall elements of the respective tanks, so that the top plate elements of tanks with different height dimensions are arranged on the same level, when the tanks are supported by the support rail, wherein the support rail may be formed from multiple support rail sections, so that the clean room bag is foldable. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to LENORA A. ABEL whose telephone number is (571)272-8270. The examiner can normally be reached Monday-Friday 7:00am-4:00pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Michael Marcheschi can be reached at (571) 272-1374. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /LENORA A ABEL/Examiner, Art Unit 1799 /MICHAEL L HOBBS/Primary Examiner, Art Unit 1799
Read full office action

Prosecution Timeline

Jun 21, 2024
Application Filed
Oct 29, 2026
Non-Final Rejection mailed — §102, §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12735667
CELL CULTURE SUBSTRATE AND CELL CULTURE SCAFFOLD KIT
3y 6m to grant Granted Sep 15, 2026
Patent 12728416
LIQUID SENSOR ASSEMBLY, APPARATUS, AND METHODS
5y 1m to grant Granted Sep 08, 2026
Patent 12692468
BACTERIOSTATIC FILTER SYSTEM FOR ANTIBODY DRUGS PRODUCTION PROCESS, AND METHOD OF OPERATING SAME
3y 10m to grant Granted Jul 28, 2026
Patent 12680070
DEVICE AND METHOD FOR SINGLE-CELL HIGH-THROUGHPUT SORTING IN MARINE IN-SITU ENVIRONMENT
3y 5m to grant Granted Jul 14, 2026
Patent 12662653
Cell Expansion
3y 4m to grant Granted Jun 23, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
69%
Grant Probability
99%
With Interview (+33.4%)
3y 2m (~10m remaining)
Median Time to Grant
Low
PTA Risk
Based on 212 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month